Drug Safety Update - November 2024
The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for November 2024 (PDF).
This issue reminds clinicians that this week is MedSafetyWeek. This is an annual social media campaign and the theme this year stresses the "importance of using medicines in the right way to prevent side effects, and to report side effects when they do occur". Healthcare professionals are encouraged to support the campaign, report suspected adverse drug reactions and talk to their patients and colleagues about side effects and how to report suspected safety concerns to the Yellow Card scheme.
Lastly, this issue contains a summary of letters to healthcare professionals in October. These generally related to supply issues and recalls but included a letter regarding the small increase in risk of developing meningioma with high doses (injectable and ≥100 mg oral formulations) of medroxyprogesterone acetate and measures to minimise this risk.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
| « CKS Updates - October 2024 | SMC Update - November 2024 » |
Leave a Comment